CLASSICAL HODGKIN LYMPHOMA
Clinical trials for CLASSICAL HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CLASSICAL HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for CLASSICAL HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a Cancer-Fighting immune drug help kids with tough tumors?
Disease control Recruiting nowThis study tests pembrolizumab, an immunotherapy that helps the immune system attack cancer, in children aged 6 months to 18 years with advanced melanoma, solid tumors, or lymphomas that have spread, returned, or not responded to treatment. The goal is to see if the drug can shri…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Apr 29, 2026 03:24 UTC
-
Lifestyle makeover for lymphoma survivors: a new hope for better living
Symptom relief Recruiting nowThis study tests whether a personalized healthy lifestyle plan can improve quality of life for people who have survived lymphoma (Hodgkin or certain types of non-Hodgkin). About 552 survivors, aged 18-50 and in remission for 3-10 years, will be randomly assigned to receive the li…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: NA • Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Symptom relief
Last updated Apr 29, 2026 03:24 UTC